https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-04-12 / Biomed Pharmacother 2023 Jun;162:114685
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-04-12 / Biomed Pharmacother 2023 Jun;162:1146852023-04-12 00:00:002023-04-12 00:00:00Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-200
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-2002023-02-17 00:00:002023-02-17 00:00:00Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-13 / NPJ Breast Cancer 2023 Feb;9(1):7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-13 / NPJ Breast Cancer 2023 Feb;9(1):72023-02-13 00:00:002023-02-13 00:00:00Immunotherapy in breast cancer: an overview of current strategies and perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-17 / Biomedicines 2023 Jan;11(2)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-17 / Biomedicines 2023 Jan;11(2)2023-01-17 00:00:002023-01-17 00:00:00Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-09-12 / Front Mol Biosci 2022;9:754100
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-09-12 / Front Mol Biosci 2022;9:7541002022-09-12 00:00:002022-09-12 00:00:003-Dimensional coculture of breast cancer cell lines with adipose tissue-Derived stem cells reveals the efficiency of oncolytic Newcastle disease virus infection labeling technology
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-03 / J Control Release 2022 Sep;349:844-875
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-03 / J Control Release 2022 Sep;349:844-8752022-08-03 00:00:002022-08-03 00:00:00Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-22 / Front Mol Biosci 2022;9:816510
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-22 / Front Mol Biosci 2022;9:8165102022-07-22 00:00:002023-03-07 13:25:25Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-06-17 / Pharm Res 2022 Aug;39(8):1851-1866
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-06-17 / Pharm Res 2022 Aug;39(8):1851-18662022-06-17 00:00:002022-06-17 00:00:00Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-01-06 / Expert Rev Vaccines 2022 Mar;21(3):337-353
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-01-06 / Expert Rev Vaccines 2022 Mar;21(3):337-3532022-01-06 00:00:002022-01-06 00:00:00Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-23 / Ther Adv Med Oncol 2021;13:17588359211064653
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-23 / Ther Adv Med Oncol 2021;13:175883592110646532021-12-23 00:00:002021-12-23 00:00:00Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis
